
Merck Q1 Profit Tops Estimates; Trims FY25 Adj. EPS Outlook
Biopharmaceutical company Merck & Co., Inc. (MRK) reported Thursday a net profit for the first quarter that grew 7 percent from last year, primarily reflecting improved gross margins and lower restructuring costs, despite a 2 percent sales drop and …